Fresenius Medical Care AG & Co. (Pref) Company Profile (ETR:FME)

About Fresenius Medical Care AG & Co. (Pref) (ETR:FME)

Fresenius Medical Care AG & Co. (Pref) logoFresenius Medical Care AG & Co. KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment, and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized ESRD patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and water treatment systems for the treatment of ESRD; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, and endovascular specialty, as well as hospitalist and intensivist, and medical cost management services. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; and offers laboratory services that include general testing, clinical anatomic pathology, and molecular testing. The company sells its products to clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of December 31, 2016, it operated 3,624 dialysis clinics in approximately 45 countries worldwide. Fresenius Medical Care AG & Co. KGaA was founded in 1996 and is headquartered in Bad Homburg, Germany.

Industry, Sector and Symbol: Average Prices:
  • 50 Day Moving Avg: €81.16
  • 200 Day Moving Avg: €82.17
P/E:
  • Trailing P/E Ratio: 21.008
  • P/E Growth: 0.000
Dividend:
  • Dividend Yield: 1.0%
Profitability:
  • Net Margins: 7.56%
  • Return on Equity: 10.85%
  • Return on Assets: 5.37%
 

Frequently Asked Questions for Fresenius Medical Care AG & Co. (Pref) (ETR:FME)

What is Fresenius Medical Care AG & Co. (Pref)'s stock symbol?

Fresenius Medical Care AG & Co. (Pref) trades on the ETR under the ticker symbol "FME."

Where is Fresenius Medical Care AG & Co. (Pref)'s stock going? Where will Fresenius Medical Care AG & Co. (Pref)'s stock price be in 2017?

19 brokers have issued 12 month price targets for Fresenius Medical Care AG & Co. (Pref)'s shares. Their predictions range from €80.00 to €97.00. On average, they anticipate Fresenius Medical Care AG & Co. (Pref)'s share price to reach €89.46 in the next twelve months. View Analyst Ratings for Fresenius Medical Care AG & Co. (Pref).

Who are some of Fresenius Medical Care AG & Co. (Pref)'s key competitors?

Who are Fresenius Medical Care AG & Co. (Pref)'s key executives?

Fresenius Medical Care AG & Co. (Pref)'s management team includes the folowing people:

  • Gerd Krick, Chairman of the Supervisory Board
  • Rice Powell, Chairman of the Management Board, Chief Executive Officer
  • Dieter Schenk, Vice Chairman of the Supervisory Board
  • Michael Brosnan, Chief Financial Officer, Member of the Management Board
  • Harry De Wit, Chief Executive Officer for Asia-Pacific, Member of the Management Board
  • Olaf Schermeier, Chief Executive Officer for Global Research and Development, Member of the Management Board
  • William Valle, Chief Executive Officer for North America, Member of the Management Board
  • Kent Wanzek, Chief Executive Officer for Global Manufacturing & Quality, Member of the Management Board
  • Dominik Wehner, Chief Executive Officer for Europe, Middle East and Africa (EMEA), Member of the Management Board
  • Ben J. Lipps, Honorary Chairman


MarketBeat Community Rating for Fresenius Medical Care AG & Co. (Pref) (ETR FME)
Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  586 (Vote Outperform)
Underperform Votes:  393 (Vote Underperform)
Total Votes:  979
MarketBeat's community ratings are surveys of what our community members think about Fresenius Medical Care AG & Co. (Pref) and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Fresenius Medical Care AG & Co. (Pref) (ETR:FME) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 9 Hold Ratings, 10 Buy Ratings
Consensus Rating:Buy (Score: 2.53)
Consensus Price Target: €89.46
Consensus Price Target History for Fresenius Medical Care AG & Co. (Pref) (ETR:FME)
Price Target History for Fresenius Medical Care AG & Co. (Pref) (ETR:FME)
Analysts' Ratings History for Fresenius Medical Care AG & Co. (Pref) (ETR:FME)
Show:
DateFirmActionRatingPrice TargetDetails
10/11/2017J P Morgan Chase & CoSet Price TargetBuy€95.10View Rating Details
9/29/2017Goldman Sachs Group, Inc. (The)Set Price TargetBuy€97.00View Rating Details
9/19/2017Berenberg BankSet Price TargetBuy€95.60View Rating Details
9/15/2017Morgan StanleySet Price TargetBuy€90.00View Rating Details
8/8/2017Citigroup Inc.Set Price TargetBuy€92.00View Rating Details
8/8/2017Deutsche Bank AGSet Price TargetNeutral€84.00View Rating Details
8/8/2017Independent Research GmbHSet Price TargetNeutral€88.00View Rating Details
8/7/2017Commerzbank AgSet Price TargetNeutral€88.00View Rating Details
8/3/2017Nord/LBSet Price TargetBuy€93.00View Rating Details
8/2/2017Kepler Capital MarketsSet Price TargetBuy€95.00View Rating Details
8/2/2017Jefferies Group LLCSet Price TargetNeutral€83.00View Rating Details
8/1/2017S&P GlobalSet Price TargetBuy€95.00View Rating Details
7/20/2017Oddo SecuritiesSet Price TargetBuy€95.00View Rating Details
5/5/2017Societe GeneraleSet Price TargetNeutral€90.00View Rating Details
4/26/2017HSBC Holdings plcSet Price TargetNeutral€83.00View Rating Details
2/22/2017Warburg ResearchSet Price TargetNeutral€85.00View Rating Details
10/27/2016Bankhaus LampeSet Price TargetNeutral€80.00View Rating Details
10/27/2016S&P Global Inc.Set Price TargetNeutral€81.00View Rating Details
10/25/2016Credit Suisse GroupSet Price TargetBuy€90.00View Rating Details
8/9/2016Barclays PLCSet Price TargetSell€72.00View Rating Details
8/3/2016BNP ParibasSet Price TargetNeutral€80.00View Rating Details
8/2/2016Baader BankSet Price TargetBuy€90.00View Rating Details
6/27/2016Sanford C. BernsteinSet Price TargetBuy€92.00View Rating Details
5/24/2016Bank of America CorporationSet Price TargetBuy€94.00View Rating Details
3/17/2016NomuraSet Price TargetBuy€99.00View Rating Details
10/29/2015S&P Equity ResearchSet Price TargetNeutral€79.00View Rating Details
(Data available from 10/18/2015 forward)

Earnings

Earnings History for Fresenius Medical Care AG & Co. (Pref) (ETR:FME)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Fresenius Medical Care AG & Co. (Pref) (ETR:FME)

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Fresenius Medical Care AG & Co. (Pref) (ETR:FME)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Fresenius Medical Care AG & Co. (Pref) (ETR:FME)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for Fresenius Medical Care AG & Co. (Pref) (ETR:FME)
Latest Headlines for Fresenius Medical Care AG & Co. (Pref) (ETR:FME)
Source:
DateHeadline
americanbankingnews.com logoFresenius Medical Care AG & Co. (Pref) (FME) Given Average Rating of "Hold" by Analysts
www.americanbankingnews.com - October 4 at 8:44 PM
americanbankingnews.com logoFresenius Medical Care AG & Co. (Pref) (FME) PT Set at €97.00 by Goldman Sachs Group, Inc. (The)
www.americanbankingnews.com - September 29 at 7:18 PM
americanbankingnews.com logoFresenius Medical Care AG & Co. (Pref) (FME) Given a €97.00 Price Target at Goldman Sachs Group, Inc. (The)
www.americanbankingnews.com - September 24 at 5:20 PM
americanbankingnews.com logoBerenberg Bank Reiterates €95.60 Price Target for Fresenius Medical Care AG & Co. KGaA (FME)
www.americanbankingnews.com - September 19 at 6:30 AM
americanbankingnews.com logoFresenius Medical Care AG & Co. KGaA (FME) Given a €90.00 Price Target by Morgan Stanley Analysts
www.americanbankingnews.com - September 15 at 10:00 AM
finance.yahoo.com logoFresenius Medical Care unveils Malaysia's first Peritoneal Dialysis products Manufacturing Plant
finance.yahoo.com - September 14 at 7:20 PM
americanbankingnews.com logoJ P Morgan Chase & Co Reiterates €95.10 Price Target for Fresenius Medical Care AG & Co. KGaA (FME)
www.americanbankingnews.com - September 14 at 6:36 AM
americanbankingnews.com logoFresenius Medical Care AG & Co. KGaA (FME) Receives Average Recommendation of "Hold" from Analysts
www.americanbankingnews.com - September 9 at 5:12 PM
prnewswire.com logoAustralia Nephrology and Urology Devices Market Outlook to 2023 - Incontinence Devices, Lithotripters and Renal Dialysis Equipment
www.prnewswire.com - August 28 at 6:27 PM
americanbankingnews.com logoFresenius Medical Care AG & Co. KGaA (FME) Given Consensus Rating of "Hold" by Brokerages
www.americanbankingnews.com - August 15 at 8:50 PM
americanbankingnews.com logoCommerzbank Ag Analysts Give Fresenius Medical Care AG & Co. KGaA (FME) a €88.00 Price Target
www.americanbankingnews.com - August 7 at 9:56 PM
seekingalpha.com logoFresenius Medical Care AG & Co. KGAA (FMS) To Buy NxStage for $2B - Slideshow
seekingalpha.com - August 7 at 4:13 PM
marketwatch.com logoFresenius Medical Care to buy NxStage for $2 bln
www.marketwatch.com - August 7 at 3:38 AM
americanbankingnews.com logoNord/LB Analysts Give Fresenius Medical Care AG & Co. KGaA (FME) a €93.00 Price Target
www.americanbankingnews.com - August 3 at 8:56 AM
americanbankingnews.com logoKepler Capital Markets Analysts Give Fresenius Medical Care AG & Co. KGaA (FME) a €95.00 Price Target
www.americanbankingnews.com - August 2 at 12:28 PM
americanbankingnews.com logoFresenius Medical Care AG & Co. KGaA (FME) Given a €106.40 Price Target by J P Morgan Chase & Co Analysts
www.americanbankingnews.com - August 2 at 9:22 AM
seekingalpha.com logoFresenius Medical Care AG & Co. KGAA 2017 Q2 - Results - Earnings Call Slides
seekingalpha.com - August 1 at 7:20 PM
americanbankingnews.com logoFresenius Medical Care AG & Co. KGaA (FME) Given a €88.00 Price Target at Commerzbank Ag
www.americanbankingnews.com - August 1 at 10:20 AM
americanbankingnews.com logoFresenius Medical Care AG & Co. KGaA (ETR:FME) Given a €68.00 Price Target by UBS AG Analysts
www.americanbankingnews.com - August 1 at 10:20 AM
americanbankingnews.com logoFresenius Medical Care AG & Co. KGaA (ETR:FME) PT Set at €92.10 by Berenberg Bank
www.americanbankingnews.com - August 1 at 10:20 AM
americanbankingnews.com logoFresenius Medical Care AG & Co. KGaA (ETR:FME) Given a €106.40 Price Target by J P Morgan Chase & Co Analysts
www.americanbankingnews.com - July 27 at 2:05 PM
americanbankingnews.com logoDeutsche Bank AG Analysts Give Fresenius Medical Care AG & Co. KGaA (ETR:FME) a €85.00 Price Target
www.americanbankingnews.com - July 24 at 9:04 AM
americanbankingnews.com logoFresenius Medical Care AG & Co. KGaA (FME) Given Average Rating of "Hold" by Analysts
www.americanbankingnews.com - July 21 at 8:46 PM
americanbankingnews.com logoFresenius Medical Care AG & Co. KGaA (FME) Given a €95.00 Price Target by Oddo Securities Analysts
www.americanbankingnews.com - July 20 at 11:10 AM
americanbankingnews.com logoFresenius Medical Care AG & Co. KGaA (FME) Given a €68.00 Price Target by UBS AG Analysts
www.americanbankingnews.com - July 14 at 9:38 AM
americanbankingnews.com logoGoldman Sachs Group, Inc. (The) Analysts Give Fresenius Medical Care AG & Co. (Pref) (FME) a €100.00 Price Target
www.americanbankingnews.com - July 1 at 2:28 PM
americanbankingnews.com logoFresenius Medical Care AG & Co. (Pref) (ETR:FME) Given a €95.00 Price Target at Berenberg Bank
www.americanbankingnews.com - July 1 at 1:16 PM
finanznachrichten.de logoFRESENIUS MEDICAL CARE AG & CO KGAA
www.finanznachrichten.de - May 15 at 4:53 PM
nasdaq.com logoFresenius Medical Care Q1 Profit Rises, Adj. Revenue Up 14%; Confirms Outlook
www.nasdaq.com - May 3 at 8:28 AM
seekingalpha.com logoFresenius Medical Care AG & Co. (FMS) Presents At Bankhaus Lampe Deutschlandkonferenz - Slideshow
seekingalpha.com - March 30 at 5:39 PM
seekingalpha.com logoFresenius Medical Care AG & Co. KGAA 2016 Q4 - Results - Earnings Call Slides
seekingalpha.com - February 22 at 10:36 AM
reuters.com logoBRIEF-Fresenius Medical Care acquires majority stake in Cura Group
www.reuters.com - February 3 at 5:38 PM
reuters.com logoBRIEF-Fresenius Medical Care reaches agreement on outstanding payments
www.reuters.com - January 31 at 5:57 PM
reuters.com logoBRIEF-Fresenius Medical Care: U.S. court grants temporary restraining order
www.reuters.com - January 13 at 11:09 PM
uk.finance.yahoo.com logoFresenius Medical Care AG & Co. KGaA: Impact of potential regulation change
uk.finance.yahoo.com - January 6 at 10:47 PM
uk.finance.yahoo.com logoFresenius Medical Care AG & Co. KGaA will focus on IFRS reporting and discontinue U.S. GAAP financial statements
uk.finance.yahoo.com - December 1 at 7:49 AM
streetinsider.com logoForm 6-K Fresenius Medical Care For: Nov 17
www.streetinsider.com - November 17 at 10:13 PM

Social

Social activity is not available for this stock.
This page was last updated on 10/18/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.